Get the Stockscreener App
70.26
4.77%
-3.52
Pre-market:
70.25
-0.01
-0.01%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $70.26, with a volume of 13.32M.
It is down -4.77% in the last 24 hours and up +7.20% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$73.78
Open:
$73.83
24h Volume:
13.32M
Relative Volume:
1.84
Market Cap:
$89.11B
Revenue:
$386.46B
Net Income/Loss:
$4.49B
P/E Ratio:
19.63
EPS:
3.58
Net Cash Flow:
$4.78B
1W Performance:
-3.95%
1M Performance:
+7.20%
6M Performance:
+5.92%
1Y Performance:
+21.66%
1-Day Range:
$69.60
$73.99
1-Week Range:
$69.60
$74.53
52-Week Range:
$43.56
$74.53
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
70.26 | 93.58B | 386.46B | 4.49B | 4.78B | 3.58 |
|
UNH
Unitedhealth Group Inc
|
320.25 | 285.64B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CI
Cigna Group
|
300.89 | 81.50B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
308.16 | 70.62B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
310.38 | 37.03B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health Corp. (NYSE:CVS): Is there more Downside to the Stock? - MSN
Vident Advisory LLC Trims Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
CVS Drops on Investor Worries About Government Ratings - Bloomberg.com
Parkman Healthcare Partners LLC Has $33.65 Million Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Bought by New England Asset Management Inc. - MarketBeat
State of Wyoming Acquires New Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Bought by Alliancebernstein L.P. - MarketBeat
First Manhattan CO. LLC. Sells 13,240 Shares of CVS Health Corporation $CVS - MarketBeat
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
AQR Capital Management LLC Has $249.15 Million Position in CVS Health Corporation $CVS - MarketBeat
AlTi Global Inc. Cuts Stake in CVS Health Corporation $CVS - MarketBeat
13,153 Shares in CVS Health Corporation $CVS Purchased by National Wealth Management Group LLC - MarketBeat
Is CVS Health Stock Outperforming the Dow? - MSN
New York governor issues order to bypass Trump administration's COVID vaccine limits - Reuters
Amundi Sells 2,295,578 Shares of CVS Health Corporation $CVS - MarketBeat
Does CVS Health Corporation outperform in volatile marketsForecast Cut & AI Powered Buy and Sell Recommendations - خودرو بانک
8 Knots Management LLC Increases Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS, Walgreens To Buy Pharmacy Assets From Rite Aid Corp: Retail Sentiment Brightens - MSN
CVS (CVS) Faces Lawsuit After Dropping Eli Lilly's Drug from Cov - GuruFocus
CVS Caremark facing class action suit for dropping coverage of Lilly's Zepbound - Seeking Alpha
CVS Health (CVS): Bernstein Maintains Rating, Raises Price Targe - GuruFocus
Bernstein Raises CVS Health's PT to $77 from $72, Maintains Market Perform - AInvest
BW Gestao de Investimentos Ltda. Lowers Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Canada Pension Plan Investment Board - MarketBeat
Panagora Asset Management Inc. Raises Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Baird Financial Group Inc. Increases Stake in CVS Health Corporation $CVS - MarketBeat
OMERS ADMINISTRATION Corp Sells 7,705 Shares of CVS Health Corporation $CVS - MarketBeat
How high can CVS Health Corporation stock goWeekly Market Outlook & Fast Exit and Entry Trade Guides - Newser
CVS Caremark’s Boosting of Wegovy Over Zepbound Fuels Lawsuits - Bloomberg Law News
Key metrics from CVS Health Corporation’s quarterly dataWeekly Trend Recap & Long-Term Safe Investment Plans - Newser
CVS Health Corporation $CVS Shares Sold by Chiron Capital Management LLC - MarketBeat
Is CVS Health Stock Outperforming The Dow? - Barchart.com
Risk adjusted return profile for CVS Health Corporation analyzedEarnings Overview Summary & Low Volatility Stock Suggestions - Newser
Caisse DE Depot ET Placement DU Quebec Reduces Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) Given Average Rating of "Buy" by Brokerages - MarketBeat
CVS Caremark Faces Lawsuit for Favoring Wegovy Over Zepbound (1) - Bloomberg Law News
10 Top-Performing Dividend Stocks - Morningstar
Lansforsakringar Fondforvaltning AB publ Sells 11,537 Shares of CVS Health Corporation $CVS - MarketBeat
Can CVS Health Corporation rally from current levelsPortfolio Risk Summary & Technical Pattern Alert System - Newser
Updated flu vaccinations now available at CVS Pharmacy® and MinuteClinic® - Yahoo Finance
Te Ahumairangi Investment Management Ltd Trims Position in CVS Health Corporation $CVS - MarketBeat
Volatility clustering patterns for CVS Health Corporation2025 Risk Factors & Weekly Setup with ROI Potential - Newser
Is CVS Health Corporation forming a double bottomJuly 2025 Breakouts & Growth Focused Stock Reports - خودرو بانک
CVS Health Corporation $CVS Shares Sold by Rafferty Asset Management LLC - MarketBeat
Ieq Capital LLC Purchases 180,495 Shares of CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):